Drug Shortage Report for ARSENIC TRIOXIDE FOR INJECTION

Last updated on 2025-01-23 History
Report ID 235163
Drug Identification Number 02492768
Brand name ARSENIC TRIOXIDE FOR INJECTION
Common or Proper name ARSENIC TRIOXIDE FOR INJECTION
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) ARSENIC TRIOXIDE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes PACK OF 10 VIALS
ATC code L01XX
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2024-08-31
Actual start date
Estimated end date 2025-09-05
Actual end date
Shortage status Actual shortage
Updated date 2025-01-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v9 2025-01-23 French Compare
v8 2025-01-23 English Compare
v7 2025-01-08 French Compare
v6 2025-01-08 English Compare
v5 2024-10-01 French Compare
v4 2024-10-01 English Compare
v3 2024-09-01 English Compare
v2 2024-08-13 French Compare
v1 2024-08-13 English Compare

Showing 1 to 9 of 9